Protein kinase G confers survival advantage to Mycobacterium tuberculosis during latency-like conditions

J Biol Chem. 2017 Sep 29;292(39):16093-16108. doi: 10.1074/jbc.M117.797563. Epub 2017 Aug 18.

Abstract

Protein kinase G (PknG), a thioredoxin-fold-containing eukaryotic-like serine/threonine protein kinase, is a virulence factor in Mycobacterium tuberculosis, required for inhibition of phagolysosomal fusion. Here, we unraveled novel functional facets of PknG during latency-like conditions. We found that PknG mediates persistence under stressful conditions like hypoxia and abets drug tolerance. PknG mutant displayed minimal growth in nutrient-limited conditions, suggesting its role in modulating cellular metabolism. Intracellular metabolic profiling revealed that PknG is necessary for efficient metabolic adaptation during hypoxia. Notably, the PknG mutant exhibited a reductive shift in mycothiol redox potential and compromised stress response. Exposure to antibiotics and hypoxic environment resulted in higher oxidative shift in mycothiol redox potential of PknG mutant compared with the wild type. Persistence during latency-like conditions required kinase activity and thioredoxin motifs of PknG and is mediated through phosphorylation of a central metabolic regulator GarA. Finally, using a guinea pig model of infection, we assessed the in vivo role of PknG in manifestation of disease pathology and established a role for PknG in the formation of stable granuloma, hallmark structures of latent tuberculosis. Taken together, PknG-mediated GarA phosphorylation is important for maintenance of both mycobacterial physiology and redox poise, an axis that is dispensable for survival under normoxic conditions but is critical for non-replicating persistence of mycobacteria. In conclusion, we propose that PknG probably acts as a modulator of latency-associated signals.

Keywords: Mycobacterium tuberculosis; hypoxia; mycobacteria; redox signaling; serine/threonine protein kinase; thioredoxin.

MeSH terms

  • Amino Acid Motifs
  • Amino Acid Substitution
  • Animals
  • Antibiotics, Antitubercular / pharmacology
  • Antigens, Bacterial / genetics
  • Antigens, Bacterial / metabolism*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Female
  • Gene Deletion
  • Granuloma / etiology*
  • Granuloma / metabolism
  • Granuloma / microbiology
  • Guinea Pigs
  • Isoniazid / pharmacology
  • Kinetics
  • Latent Tuberculosis / metabolism
  • Latent Tuberculosis / microbiology*
  • Latent Tuberculosis / physiopathology
  • Metabolomics / methods
  • Microbial Viability / drug effects
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / growth & development
  • Mycobacterium tuberculosis / metabolism*
  • Mycobacterium tuberculosis / physiology
  • Phosphorylation / drug effects
  • Point Mutation
  • Protein Processing, Post-Translational* / drug effects
  • Protein Serine-Threonine Kinases / chemistry
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Stress, Physiological

Substances

  • Antibiotics, Antitubercular
  • Antigens, Bacterial
  • Bacterial Proteins
  • CFP17 protein, Mycobacterium tuberculosis
  • Protein Serine-Threonine Kinases
  • protein kinase G, Mycobacterium tuberculosis
  • Isoniazid